News Search Results
Feb 28, 2025, 09:00 ET Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting
Phase 2a clinical trial of bempikibart in patients with alopecia areata (AA) will be presented in a late-breaking oral session at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place March 7-11 in Orlando, FL. Bempikibart
More news about: Q32 Bio
Feb 28, 2025, 09:00 ET Novartis data presentations at AAAAI and AAD underscore commitment to advancing treatment of hidradenitis suppurativa (HS) and chronic spontaneous urticaria (CSU)
at the 2025 American Academy of Allergy Asthma and Immunology (AAAAI) and World Allergy Organization (WAO) Joint Congress and the 2025 American Academy of Dermatology (AAD) Annual Meeting. Data presented at the congresses include long-term urticaria control, sleep, and activity analyses from the
More news about: Novartis Pharmaceuticals Corporation
Feb 26, 2025, 08:00 ET Kyowa Kirin Announces Late-Breaking Abstract Presentation at the American Academy of Dermatology Annual Meeting 2025
investigational therapy targeting the OX40 receptor (OX40R) in patients with moderate-to-severe atopic dermatitis (AD), will be presented at the American Academy of Dermatology (AAD) 2025 Annual Meeting to be held in Orlando, Florida from March 7-11, 2025.
More news about: Kyowa Kirin
Feb 13, 2025, 09:00 ET NavaDerm and LSSCNY Announce Change in Clinical Leadership
appointment in the Department of Plastic Surgery/Dermatology at Mount Sinai Hospital / New York Eye and Ear Infirmary. He is a Fellow of the American Academy of Dermatology, American Society of Lasers in Medicine and Surgery, the American College of Mohs Micrographic Surgery and Cutaneous Oncology, and the
More news about: BelHealth Investment Partners